Regenerative Medicine Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts 2017 to 2025, Focusing on Top Key Vendors


Regenerative medicine is an interdisciplinary subject that encompasses engineering tools and molecular biological techniques to fix impairment of body’s cells, organ or tissues by making them to grow again. Regenerative medicines are capable of healing and reviving functionality of cells and tissues damaged by disease, accident, aging or any sort of trauma. It may include use of cells as delivery vehicle carrying therapeutic agents such as genes & cytokines, progenitor cells or tissues, transplantation of stem cells or body’s own repair mechanism. Stem cells plays crucial role in regenerative medicine as they have the potential to proliferate and differentiate on their own.


Market Growth Factors

Various factors are promoting the global regenerative medicine market growth such as wide acceptance of stem cell technology, up surging application of nanotechnology in disease cure like cancer, growing prevalence of chronic and acute disease and accidental emergencies. In addition, advancement in effective and developed technology, rising funding and supportive initiatives from government and private organizations to assist in the development of regenerative medicinal products and increased awareness among people are vital factors responsible for the increasing development of this sector. However, highly rigorous regenerative process, unaffordable treatment associated with regenerative medicine and high investment in research and development might restrict the market for future growth. Favourable circumstances for novel stem cell technology to expand, increasing demand for regenerative medicine in organ transplantation and increased potential of developed countries facilitates the opportunity to new players to enter the market.

Get a Free Sample Report @



The global regenerative medicine market is differentiated based on therapy, product, application and region. On the basis of therapy the market is divided into cell therapy, gene therapy, tissue engineering and immune therapy. Cell therapy is expected to record growth at rapid pace owing to increased funding of private sectors & various organization, worldwide awareness programme and conferences about the benefits of stem cell therapy, inclined shift of healthcare industry towards stem cell therapy and burgeoning research and development in the particular field. Considering product type the market is organized into autologous cell based, allogenic cell based and acellular. Depending upon the application the market is classified into dermatology, cardiology, musculoskeletal and orthopaedic disorders.


Regional Analysis

The global regenerative medicine market is regionally segmented into-

• North America

  o US

  o Canada

  o Mexico

• Europe

  o UK

  o Germany

  o France

  o Italy

  o Spain

  o Rest of Europe

• Asia-Pacific

  o China

  o India

  o Japan

  o Australia

  o South Korea

  o Rest of Asia-Pacific


  o Brazil

  o UAE

  o South Africa

  o Rest of the LAMEA


North America is anticipated to grow lucratively owing to advancement in technology, proper reimbursement facilities and increased knowledge about regenerative medicine specifically stem cell technology. Factors like modernization in healthcare facilities, awareness among people, satisfactory government policies in emerging economies such as India and China are expected to flourish the regenerative medicine market in Asia-Pacific region.

View Full Report @


Competitive Analysis

Key players in the global regenerative market include-

  • Baxter International Inc
  • DePuy Synthes Inc
  • Acelity Holdings
  • Stryker Corporation
  • Medtronic Inc
  • Capricor Therapeutics
  • Integra LifeSciences Corporation
  • Medtronic Inc
  • Organogenesis
  • NuVasive
  • Zimmer Biomet Holdings


Latest News

Capricor is clinical stage biotechnology based company targeting on discovery, development and commercialization of biological therapeutics in order to treat rare disorders.  on 5th February 2018 U.S. Food and drug administration has granted regenerative medicine advanced therapy designation to capricors’s a lead candidate, CAP-1002, cell therapy which is in clinical development for the treatment of Duchenne muscular dystrophy. CAP-1002 is allogenic product consist of cardiosphere-derived cells, a unique population of cells which include progenitor cells having potent immunomodulatory activity.


About Us:
Garner Insights ( is a Market Intelligence and Business Consulting firm led by professionals with a vast experience and knowledge of the market research industry.

Our vast repository of research reports across various categories gives you a complete view of the ever-evolving trends and current topics worldwide. Our constant focus is on improving the data and finding innovative methods, which will help your business drive profitable growth.

The research methodology is designed to cater all your research needs which is backed by exclusive quantitative and analytics-driven intelligence. It consists of primary and secondary methods which is a testimony of the information comprised. The meticulous and distinct data gathering methods are in line with the highest standards of data mining in the industry.

We have a plethora bank of publishers who share their various quality reports using our platform and expertise. The data bank is monitored by the team of experts which is validated by various statistical data and trending content.

Media Contact
Company Name: Garner Insights
Contact Person: Kevin Thomas
Phone: +1 513 549 5911
City: Pune
Country: India